GlassScriptPhysician profile
Alejandro N Lopez
NPI 1639126733
$12,195.02
in general payments reported to CMS, 2019-2025
45 companies · $2,812 in 2025
The $2,812 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,286 · 2020: $291 · 2021: $1,306 · 2022: $1,954 · 2023: $2,380 · 2024: $2,166 · 2025: $2,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,048 · Travel and Lodging: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,047.56 |
| Travel and Lodging | $310.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,964.45 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $1,684.54 | 2019-2025 | Optis, Xience Sierra, Diamondback Coronary |
| Abiomed | $1,004.29 | 2019-2025 | Impella |
| Medtronic, INC. | $868.77 | 2021-2025 | Abre, Hawkone, Onyx Frontier |
| Boston Scientific Corporation | $789.06 | 2019-2025 | Opticross, Wolverine Coronary Cutting Balloon, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $776.97 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $684.38 | 2019-2024 | Xarelto |
| Atricure, INC. | $392.53 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $392.52 | 2019-2025 | Lifevest |
| Stryker Corporation | $371.77 | 2025 | Flowtriever, Clottriever Bold Catheter, Venacore Thrombectomy Catheter |
| Recor Medical INC | $286.85 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Merck Sharp & Dohme LLC | $283.19 | 2021-2025 | Verquvo |
| Pfizer INC. | $267.43 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $250.45 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $233.80 | 2019-2025 | Farxiga, Wainua, Lokelma |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $200.77 | 2019-2025 | Kengreal |
| Amgen INC. | $185.03 | 2021-2025 | Repatha, Repatha |
| Heartflow, INC. | $176.84 | 2025 | |
| Cardiva Medical, INC. | $155.49 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $153.01 | 2023-2025 | Coronary Other, Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Bridgebio Pharma, INC. | $110.39 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $100.97 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiovascular Systems INC. | $80.40 | 2019-2021 | |
| Gilead Sciences, INC. | $67.63 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $67.60 | 2022-2024 | Opsumit, Uptravi |
| Alnylam Pharmaceuticals INC. | $67.45 | 2024-2025 | Onpattro |
| Angiodynamics, INC. | $67.19 | 2022-2025 | Angiovac |
| Tactile Systems Technology INC | $61.94 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Esperion Therapeutics, INC. | $60.38 | 2022-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $47.27 | 2023-2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $46.43 | 2022-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $41.12 | 2024 | Arcalyst |
| Cvrx, INC. | $32.92 | 2025 | Barostim Neo System |
| Cardinal Health 200 LLC | $28.21 | 2019 | |
| Ironshore Pharmaceuticals INC. | $24.74 | 2023 | Jornay Pm |
| Daiichi Sankyo INC. | $22.47 | 2023 | Injectafer |
| Nuwellis, INC. | $22.07 | 2019-2023 | Aquadex Smartflow Console |
| Kiniksa Pharmaceuticals, LTD. | $18.50 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $17.73 | 2024 | |
| Terumo Medical Corporation | $17.18 | 2019 | |
| Cagent Vascular INC | $15.30 | 2025 | Serrantor |
| Impulse Dynamics (USA) INC. | $14.97 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.73 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.59 | 2023 | |
| Bard Peripheral Vascular, INC. | $12.70 | 2023 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.